CY1116893T1 - Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια - Google Patents

Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια

Info

Publication number
CY1116893T1
CY1116893T1 CY20151100988T CY151100988T CY1116893T1 CY 1116893 T1 CY1116893 T1 CY 1116893T1 CY 20151100988 T CY20151100988 T CY 20151100988T CY 151100988 T CY151100988 T CY 151100988T CY 1116893 T1 CY1116893 T1 CY 1116893T1
Authority
CY
Cyprus
Prior art keywords
diabetic nephropathy
urine
alpha
indicators related
treatment indicators
Prior art date
Application number
CY20151100988T
Other languages
English (en)
Inventor
Wei-Ya Lin
Mary Ya-Ping Yeh
Tzu-Ling Tseng
Ping-Fu Cheng
Tsai-Wei Hsu
Hung-Yi Li
Yi-Ting Chen
Yuh-Feng Lin
Giien-Shuen Chen
Yen-Peng Li
Original Assignee
Industrial Technology Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10735454.0A external-priority patent/EP2391654B1/en
Application filed by Industrial Technology Research Institute filed Critical Industrial Technology Research Institute
Publication of CY1116893T1 publication Critical patent/CY1116893T1/el

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Χρήση βιοδεικτών ούρων και ορού σε διάγνωση διαβητικής νεφροπάθειας, σταδιοποίηση διαβητικής νεφροπάθειας, παρακολούθηση της εξέλιξης της διαβητικής νεφροπάθειας, και αξιολόγηση της αποτελεσματικότητας αγωγών διαβητικής νεφροπάθειας. Οι βιοδείκτες αυτοί περιλαμβάνουν πρόδρομη άλφα-2-HS-γλυκοπρωτεΐνη ούρων, άλφα-1 αντιθρυψίνη ούρων, άλφα-1 όξινη γλυκοπρωτεΐνη ούρων, οστεοποντίνη ούρων, οστεοποντίνη ορού, τα θραύσματα τους, και συνδυασμούς αυτών.
CY20151100988T 2009-01-28 2015-11-05 Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια CY1116893T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14777809A 2009-01-28 2009-01-28
EP10735454.0A EP2391654B1 (en) 2009-01-28 2010-01-27 Urine and serum biomarkers associated with diabetic nephropathy

Publications (1)

Publication Number Publication Date
CY1116893T1 true CY1116893T1 (el) 2017-04-05

Family

ID=58487014

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20151100990T CY1117159T1 (el) 2009-01-28 2015-11-05 Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια
CY20151100988T CY1116893T1 (el) 2009-01-28 2015-11-05 Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20151100990T CY1117159T1 (el) 2009-01-28 2015-11-05 Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια

Country Status (1)

Country Link
CY (2) CY1117159T1 (el)

Also Published As

Publication number Publication date
CY1117159T1 (el) 2017-04-05

Similar Documents

Publication Publication Date Title
MX2011007811A (es) Biomarcadores en orina y suero asociados con nefropatia diabetica.
IL254062B (en) Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer
EA201100335A8 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
CY1122778T1 (el) Μετεγχειρητικοι φραγμοι προσκολλησης
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
DE602006014996D1 (de) Chromansubstituierte benzimidazole und ihre verwendung als säurepumpenhemmer
ATE489389T1 (de) 2 -heteroaryl- pyrrolo ä3, 4-cüpyrrol- derivate und deren verwendung als scd inhibitoren
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
EP2451284B8 (en) Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
IT1396051B1 (it) Procedimento di minimizzazione in sito dei fanghi di depurazione dei reflui e di altri rifiuti.
EA201300583A1 (ru) Вазопротективное и кардиопротективное противодиабетическое лечение
MX356866B (es) Biomarcadores p53.
BR112013010952A2 (pt) sistemas de rmn e métodos para a detecção rápida de analisados
WO2008131361A3 (en) Biosensors for measuring analytes in the interstitial fluid
JP2006311860A5 (el)
WO2010004590A3 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
BRPI0923796A2 (pt) compostos antivirais, tratamento e ensaio
BR112012002044A2 (pt) dispositivo estimulador retal e seu uso para o tratamento de incontinência retal, fecal e/ou urinária
WO2011006161A3 (en) Compositions and methods for diagnosing and treating macular degeneration
BRPI0810028A2 (pt) Éteres de amidas de ácido naftaleno carboxílico no tratamento de câncer
CY1116893T1 (el) Βιοδεικτες ουρων και ορου οι οποιοι συνδεονται με διαβητικη νεφροπαθεια